JPRN-UMIN000017937已完成1 期
WT1 peptide vaccination for patinets with hematological CR after induction chemotherapy - WT1 peptide vaccination for patinets with hematological CR after induction chemotherapy
Cancer immunotherapy of Osaka University0 个研究点目标入组 24 人开始时间: 2015年6月17日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. double cancer 2. active infections 3. autoinflamatory disease
研究者
相似试验
已完成
1 期
WT1 peptide vaccination for pediatric patients: phase I/II study.pediatric malignant tumor, hematological malignancyJPRN-UMIN000013252Osaka University Graduate School of Medicine20
已完成
2 期
Immunotherapy with WT1 peptide vaccine for pediatric patients with bone or soft tissue sarcoma following conventional chemotherapy.Pediatric soft tissue malignancy and neuroblastomaJPRN-UMIN000013251Osaka university graduate school of medicine22
已完成
1 期
WT1 peptide-based vaccination combined with Gemcitabine for advanced pancreas cancerpancreas cancerJPRN-UMIN000001187Department of Cancer immunotherapy, Osaka University Medical School18
已完成
1 期
WT1 peptide-based vaccination combined with Gemcitabine for advanced pancreas cancerpancreas cancerJPRN-UMIN000001209Department of Internal medicine, Division of Gastroenterology and Hepatology, Kashiwa Hospital, Jikei University School of Medicine18
已完成
1 期
WT1 peptide-based vaccination combined with Gemcitabine for advanced pancreatic and biliary tract cancersadvanced pancreatic and biliary tract cancersJPRN-UMIN000004081Department of Internal medicine, Division of Gastroenterology and Hepatology, Kashiwa Hospital, Jikei University School of Medicine20